Further Information
MDG, N-methylpurine-DNA glycosylase, AAG, APNG, CRA36.1, Mid1, N-methylpurine-DNA glycosylase, MPG, PIG11, PIG16, anpg, 3' end of the Mid1 gene, localized 68 kb upstream the humanzeta globin gene on 16p, CRA36.1 (3-methyl-adenine DNA glycosylase), alkyladenine DNA glycosylase, proliferation-inducing protein 11, proliferation-inducing protein 16
Peptide ELISA: antibody detection limit dilution 1:1000.Western Blot:Approx 37kDa band observed in lysates of HEK293 and K562 (calculated MW of 32.9kDa according to NP_002425.2). Recommended concentration: 1-3ug/ml. Primary incubated for 1 hour.Immunohistochemistry:Paraffin embedded Human Uterus. Recommended concentration: 5ug/ml.
- Samson L, Derfler B, Boosalis M, Call K. Cloning and characterization of a 3-methyladenine DNA glycosylase cDNA from human cells whose gene maps to chromosome 16. Proc Natl Acad Sci USA. 1991 Oct 15;88(20):9127-31.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
The immunogen for this antibody is: C-SVVDRVAEQDTQA
4350
N-methylpurine-DNA glycosylase
MPG
Homo sapiens
Liquid
NP_002425.2, NP_001015052.1, NP_001015054.1
62632769
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Cancer
This antibody is expected to recognize all three reported isoforms (NP_002425.2, NP_001015052.1 and NP_001015054.1)
P29372